Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors
收藏NIAID Data Ecosystem2026-03-07 收录
官方服务：
资源简介：
The CC-90003-ST -001 trial is a first-in-man, open-label study in subjects with locally-advanced or wide spread cancers to determine if CC-90003 (an oral medication) can be adequately tolerated with minimal side effects.
创建时间：
2015-01-15
